Literature DB >> 29336189

Depression, sexual satisfaction, and other psychological issues in women with polycystic ovary syndrome.

Angelika Stapinska-Syniec1, Klaudia Grabowska1, Monika Szpotanska-Sikorska2, Bronislawa Pietrzak2.   

Abstract

Polycystic ovary syndrome (PCOS) increases the risk of depression, poor quality of life, and low sexual satisfaction of women. The aim of the study was to evaluate the prevalence of these disorders and to assess the need for psychological consultation at the time of PCOS diagnosis. A case-control single-center study of 250 women who were diagnosed with PCOS voluntarily filled in an anonymous, interactive questionnaire. The inquiry form included 27 questions covering the woman's characteristics, satisfaction with their outer appearance and sexual life, as well as the Beck Depression Inventory (BDI). Based on the BDI, 52% (130/250) of studied women presented depressive symptoms. This group had significantly higher body mass index (29.5 ± 8.1 vs. 24.6 ± 5.8; p<.001) and a lower level of self-attractiveness than other studied women (3.3 ± 2.2 vs. 5.4 ± 2.3; p<.001). Forty two percent (106/250) of women viewed themselves as unattractive. A correlation between reduced sexual satisfaction and a sense of low attractiveness was noted (r = 0.465, p<.001). Sixty four percent (160/250) of women believed that psychological consultation should be offered to all PCOS women. Treatment of PCOS women should be multidisciplinary and include psychological counseling, especially in obese PCOS women with inadequate family support and dissatisfied with their sexual life.

Entities:  

Keywords:  Polycystic ovary syndrome; depression; mood disorders; quality of life; sexuality

Mesh:

Year:  2018        PMID: 29336189     DOI: 10.1080/09513590.2018.1427713

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  7 in total

1.  Psychological Issues and Sexual Function in Women with Different Infertility Causes: Focus on Polycystic Ovary Syndrome.

Authors:  Iuliia Naumova; Camil Castelo-Branco; Gemma Casals
Journal:  Reprod Sci       Date:  2021-03-24       Impact factor: 3.060

2.  Exploratory study of a screening measure for polycystic ovarian syndrome, quality of life assessment, and neuropsychological evaluation.

Authors:  Michael J Boivin; Farnaz Fatehi; Amy E Phillips-Chan; Julia R Richardson; Amanda N Summers; Steven A Foley
Journal:  BMC Womens Health       Date:  2020-06-23       Impact factor: 2.809

3.  Quality of Life in Infertile Women with Polycystic Ovary Syndrome: a Comparative Study.

Authors:  Iuliia Naumova; Camil Castelo-Branco; Iuliia Kasterina; Gemma Casals
Journal:  Reprod Sci       Date:  2020-11-19       Impact factor: 3.060

4.  Association of Angiotensin-Converting Enzyme gene polymorphism in Pakistani women with the atypical steroidogenesis in Polycystic ovarian syndrome: A case-control study.

Authors:  Kiran Nazeer; Nasira Munawar Lone; Shumaila Sadique; Sikandar Sultan; Amna Zia Eupash; Saba Riaz
Journal:  Saudi J Biol Sci       Date:  2021-03-14       Impact factor: 4.219

5.  Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone).

Authors:  A Podfigurna; B Meczekalski; F Petraglia; S Luisi
Journal:  J Endocrinol Invest       Date:  2019-10-25       Impact factor: 5.467

Review 6.  Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions.

Authors:  Antonio Aversa; Sandro La Vignera; Rocco Rago; Alessandra Gambineri; Rossella E Nappi; Aldo E Calogero; Alberto Ferlin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-11       Impact factor: 5.555

7.  Sexual Function in Chinese Women with Polycystic Ovary Syndrome and Correlation with Clinical and Biochemical Characteristics.

Authors:  Xuanxuan Tian; Xiangyan Ruan; Juan Du; Juan Wang; Dongmei Yin; Jiaojiao Cheng; Rui Ju; Alfred O Mueck
Journal:  Reprod Sci       Date:  2021-06-02       Impact factor: 2.924

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.